M. Myers

发表

Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.

C. Bloomfield, R. Larson, F. Appelbaum, 2006 .

The Histone Deacetylase Inhibitor Depsipeptide Has Differential Activity in Specific Cytogenetic Subsets of Acute Myeloid Leukemia (AML).

R. Larson, D. Huo, W. Stock, 2004 .

Prognostic significance of WT-1 levels in patients with myelodysplastic syndrome and leukemia after reduced-intensity allogeneic transplantation.

J. Ulaszek, D. Huo, W. Stock, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.